WO2002004951A1 - Micro-array - Google Patents

Micro-array Download PDF

Info

Publication number
WO2002004951A1
WO2002004951A1 PCT/JP2001/002821 JP0102821W WO0204951A1 WO 2002004951 A1 WO2002004951 A1 WO 2002004951A1 JP 0102821 W JP0102821 W JP 0102821W WO 0204951 A1 WO0204951 A1 WO 0204951A1
Authority
WO
WIPO (PCT)
Prior art keywords
microarray
carrier
frame
molecule
sample
Prior art date
Application number
PCT/JP2001/002821
Other languages
French (fr)
Japanese (ja)
Inventor
Akio Yamane
Toru Miyagi
Original Assignee
Wakunaga Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co., Ltd. filed Critical Wakunaga Pharmaceutical Co., Ltd.
Priority to AU2001244687A priority Critical patent/AU2001244687A1/en
Publication of WO2002004951A1 publication Critical patent/WO2002004951A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00306Reactor vessels in a multiple arrangement
    • B01J2219/00313Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315Microtiter plates
    • B01J2219/00317Microwell devices, i.e. having large numbers of wells
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00585Parallel processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00596Solid-phase processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00659Two-dimensional arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0893Geometry, shape and general structure having a very large number of wells, microfabricated wells
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries

Definitions

  • the present invention relates to a microarray used for analyzing biomolecules, and more particularly, to a diagnostic microarray suitable for processing a large amount of a sample.
  • Analysis of gene expression at the mRNA level can be performed by analyzing a specific known gene sequence for a sample, as in the Northern blot method (Alwine JC et al. Proc Natl Acad Sci USA. 1977 Dec; 74 (12): 5350-4). There is a method used as a probe. On the other hand, conversely, genes with different expression levels among different samples, such as the differential display method (Liang P and Pardee AB. Science. 1992 Aug 14; 257 (5072): 967-71), are used. There are ways to find them.
  • Northern blotting is time-consuming and labor-intensive, and the number of genes that can be analyzed is limited. Although it is a reliable and convenient method for analyzing a small number of candidate genes, it is very difficult to analyze the vast number of genes identified one after another.
  • the differential display method a sample extracted from cells and tissues in different states and a sample amplified at random are electrophoresed, and band patterns are compared to extract bands with different intensities between different samples. And determine the base sequence. In many cases, this band does not contain the entire nucleotide sequence of the gene, and the gene is identified by comparing the partial sequence obtained from the band with the previously determined gene sequence data. You. The function can be estimated from the state of the identified gene that was strongly expressed in the cell.
  • a technique called DNA microarray or DNA chip is capable of analyzing a much larger number of genes than these methods.
  • a DNA microarray is a solid plate in which a partial amplification product of a known gene sequence or an oligonucleotide is immobilized on a small plate such as a slide glass at a high density. Thousands to tens of thousands of types are obtained by hybridization. This technology allows simultaneous detection of gene expression levels on a single slide.
  • DNA can be directly solid-phase synthesized on a carrier, or can be immobilized on a carrier by spotting a previously synthesized DNA with a fine pin or the like.
  • DNA microarrays are being developed as a very powerful technique in expression analysis and polymorphism analysis research, and clinical applications are expected to become more active in the future based on these research results ( Hodgson J. Nat Biotechnol. 1998 Aug; 16 (8): 725-7).
  • the probe is placed on a slide glass.
  • the sample solution is spread over the entire probe area by immobilizing a solid phase, placing a hybridization solution containing a detection target on a probe, and covering the probe with a cover slip.
  • the target nucleic acid group is labeled with a fluorescent substance or the like, and after hybridization, excess labeled nucleic acid not hybridized to the probe is removed by washing.
  • This method has a problem that bubbles easily enter the sample solution when a force bar slip is applied.
  • the mixed bubbles inhibit contact between the probe and the sample and cause false negatives.
  • very careful handling of force bar slips is required, and the processing of large samples takes a great deal of time.
  • the hybridization solution is present in a narrow space covered with a cover slip, and is difficult to disperse, resulting in a bias in the sample concentration, causing false negatives due to insufficient sample volume and false positives due to excessive sample volume.
  • the hybridization solution In order for the hybridization solution to be present in the force bar slip region without excess or deficiency, it is necessary to finely adjust the amount of the solution.
  • the hybrid solution When two or more probe regions are present on the same carrier and different samples are allowed to react with each probe region on this carrier, if the hybrid solution is excessive, it will be outside the cover slip region, that is, outside the probe region.
  • the hybridization solution protrudes, causing the contamination of the sample with other probe regions, which causes false positives due to cross-hybridization.
  • the force purse slip after finishing the hybridization, the force purse slip must be removed for cleaning, but the cover slip is strongly adsorbed on the carrier due to surface tension, and it is difficult to quickly remove it.
  • the present inventors improve the operability of hybridization and the reliability of analysis data by providing a frame in the detection part of the microarray and holding the sample (test liquid) on the detection part. was found.
  • An object of the present invention is to provide a microarray excellent in operability and reliability of analysis data and suitable for processing a large number of samples.
  • a microarray for detecting a plurality of target molecules a carrier for detecting a target molecule to which a molecule capable of capturing the target molecule (capture molecule) may be immobilized,
  • a microarray having at least one unit comprising a frame for holding a sample on the carrier is provided.
  • the microarray according to the present invention does not have an immobilized lid on the frame, the captured molecule can be immobilized at any time. This makes it easy to discharge and inject the washing liquid.
  • the frame is integrated in the microarray according to the present invention in advance, the work of attaching the frame in the detection step is unnecessary, and the work of removing the frame is not required because the frame does not hinder detection of the target molecule. Therefore, the microarray according to the present invention is advantageous in that it has excellent operability.
  • the microarray according to the present invention can stably hold a solution on the detection portion, it is possible to use a probe that can be detected only in a solution such as a molecular beacon probe having excellent reliability and immediacy. Become. Further, in the microarray according to the present invention, even when a plurality of samples are handled on the same carrier, contamination of each sample into another sample can be avoided by clearly dividing a plurality of detection regions by a frame. Therefore, the microarray according to the present invention is advantageous in that a reliable data without erroneous determination can be obtained and a large amount of sample can be processed. BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 is a diagram showing a microarray according to the present invention.
  • Azusa 3 is attached to carrier polystyrene 2.
  • a region surrounded by a frame 3 on the carrier polystyrene 2 is a hybridization region.
  • A is a plan view
  • B is a sectional view
  • C is a perspective view.
  • FIG. 2 is a diagram showing a microarray according to the present invention.
  • a plurality of frames 3 are detachably attached to the carrier polystyrene 2.
  • a region surrounded by a frame 3 on the carrier polystyrene 2 is a hybridization region.
  • A is a plan view
  • B is a sectional view
  • C is a perspective view.
  • FIG. 3 is a diagram showing a microarray according to the present invention.
  • a plurality of frames 3 integrated by the frame holders 14 are detachably attached to the carrier polystyrene 2 c.
  • a region surrounded by the frame 3 on the carrier polystyrene 2 is a hybridization region.
  • FIG. 4 shows a microarray set.
  • A is a diagram showing a microarray 5 and a microarray holder 16.
  • B is a diagram showing a microarray set 7 obtained by placing a plurality of microarrays 5 in a box-shaped microarray holder 6.
  • FIG. 5 is a diagram showing an embodiment in which a plurality of microarrays are integrated by fitting concave portions 8 and convex portions 9 provided on the carrier 2 and the frame holder 4 to each other.
  • a microarray set can be obtained by integrating a plurality of microarrays at uneven portions.
  • FIG. 6 is a view showing an embodiment in which a plurality of microarrays are integrated by a clip-shaped microarray holder 10.
  • a microarray set can be obtained by integrating a plurality of microarrays with the clip 10.
  • FIG. 7 is a diagram showing a frame according to the present invention.
  • a plurality of frames 3 are integrated by a frame holder 4.
  • FIG. 8 is a diagram showing the results of HLADRB1 gene tying in the examples. Detailed description of the invention
  • microarray refers to a carrier in which a group of arranged capture molecules is immobilized on a carrier or a carrier capable of immobilizing the same, and is referred to as a “detection chip” such as a DNA chip or the like.
  • the microarray according to the present invention which is used to include a carrier for preparation, comprises a carrier for detecting a target molecule and a sample (test liquid) for detecting the presence of the target molecule on a detection portion. And at least one unit consisting of: It preferably has 2 to 10 units, more preferably 2 to 5 units.
  • unit means a detection space separated by a frame.
  • the carrier constituting each unit can be a common carrier. That is, a plurality of units can be formed by installing a plurality of frames on a common carrier. See, for example, FIGS.
  • the capture molecule may be immobilized on the carrier in advance.
  • Target molecules to be detected include antigenic substances (proteins, glycoproteins, amino acids, etc.) or antibodies against them, nucleic acids (DNA, RNA, etc.), peptide nucleic acids, etc., especially during organ or bone marrow transplantation.
  • antigenic substances proteins, glycoproteins, amino acids, etc.
  • nucleic acids DNA, RNA, etc.
  • peptide nucleic acids etc., especially during organ or bone marrow transplantation.
  • HLA white blood cell type It is considered useful for tying.
  • the capture molecules for detecting these are antibodies against substances having antigenicity or substances having antigenicity, nucleic acid probes, nucleic acid probes (Hermann T and Patel DJ. Science. 2000 Feb 4; 287 (5454): 820 -5) or a peptide nucleic acid (Beier M and Hoheisel JD.Nucleic Acids Res. 1999 May l; 27 (9): 1970-7), etc., and a molecule such as streptavidin that has the ability to bind to the molecule to be detected. It may be. Preferably, it is a nucleic acid probe.
  • nucleic acid probe a synthetic oligonucleotide, a plasmid / phage, a nucleic acid amplified in a living body such as ssMA, or a nucleic acid fragment amplified in a test tube by PCR or the like can be used.
  • the capture molecules can be immobilized on the carrier by physical adsorption or chemical bonding.
  • the carrier glass surface was coated with poly-L-Lys and the positive charge of the Lys amino group was observed.
  • a typical example is one utilizing the electrostatic action between the negative charge of the phosphate bond between DNA and DNA.
  • the microphone mouth plate Inouye S and Hondo R. J Clin Microbiol. 1990
  • the capture molecules are preferably arranged on a carrier and immobilized at a high density.
  • the amount of information obtained in a single experiment is dramatically increased due to the high density of the probe, and changes in the state of the living body caused by environmental changes, diseases, administration of drugs, etc. It can be captured as an image.
  • Probe densification is described, for example, in Lipshutz RJ et al. Nat Genet. 1999 Jan; 21 (l Suppl): 20-4 and Schena M et al. Science. 1995 Oct 20; 270 (5235): 467-70.
  • the frame constituting the unit has a height sufficient to hold the test liquid on the detection portion, preferably 3 mm to 15 mm, more preferably 5 mm to 1 O mm It is.
  • the microarray according to the present invention is provided with a frame. If the frame and the carrier are integrated in advance, there is no need to attach the frame before detection. In addition, the detection of the target molecule is not hindered by the frame, so that the removal operation is not required. Therefore, it is advantageous in that the operation procedure can be simplified.
  • the frame can be removable if required.
  • the frame and the carrier can be reversibly bonded with a silicon gasket or the like.
  • the frame may have one or more projections or depressions
  • the carrier may have depressions or projections corresponding to the projections or depressions of the frame.
  • the frame and the carrier can be detachably fixed by fitting the projection or the recess of the frame with the corresponding recess or the projection of the carrier.
  • a plurality of units may be integrated by a frame holder.
  • a plurality of units may be integrated in the opening of the frame.
  • Such an embodiment is as shown in FIG.
  • a plurality of units may be integrated on one carrier so as to be arranged in a line.
  • the shape of the unit is preferably a rectangular parallelepiped, a cube, or a similar shape suitable for immobilizing the captured molecules efficiently and at high density.
  • the purpose is to prevent the test liquid from scattering and evaporating to the unit as necessary.
  • the bottom surface of a conventional microplate is a circle, and when a plurality of independent regions are arranged in parallel, capture molecules are immobilized between the regions. There were regions where the capture molecules could not be created, and the capture molecules could not be arranged efficiently.
  • the aligned capture molecules can be immobilized on the carrier at high density, and the immobilized portion can be efficiently arranged, so that one microarray can process many samples at a time. This is advantageous in that it can be performed.
  • a carrier portion where a sample solution is to be present (for example, a probe-immobilized region) is surrounded by a frame, and this frame is moved out of the probe region of the sample solution (for example, a hybridization solution). Block oozing. Therefore, the sample solution can be injected into the carrier portion without worrying that the sample solution spreads to other regions, which is advantageous in that the operation is simplified.
  • the sample solution is freely stirred by shaking.
  • the concentration of the target molecule in the solution is uneven and the bubbles from remaining on the capture molecule. Accordingly, it is advantageous in that more stable hybridization can be performed. Since the frame of the microarray according to the present invention is not covered with the lid on which the frame is fixed, the capture molecules can be immobilized at any time. Therefore, the operation procedure can be made flexible.
  • the detection area is set using an aspire with a nozzle and a dispenser. Can be washed.
  • the aspirator and the dispenser can be, for example, a microplate washer. Therefore, the microarray according to the present invention is advantageous in that the washing can be automated as in the microplate washing. Note that it is also possible to automate the washing process when preparing a microarray.
  • the removal of the washing solution after the hybridization was performed by centrifugation or air injection pressure.
  • the salt of the washing solution after the hybridization often remains. Since the salt remaining on the surface itself fluoresces, it caused non-uniform noise when the scanner sensitivity was increased, hindering the detection of trace samples. In addition, the salt remaining on the probe spot became a large crystal, which sometimes caused a false negative by blocking the excitation light and the fluorescence.
  • the present invention is also advantageous in that detection can be performed while the detection solution is retained, and such a decrease in detection sensitivity is avoided.
  • a plurality of hybridization regions can be formed by arranging frames as necessary.
  • the fact that a plurality of nodipase regions are physically separated by a frame indicates that highly homologous genes such as the human leukocyte antigen genes HLA-A and HLA-B are detected on the same carrier.
  • HLA-A and HLA-B highly homologous genes
  • it is very effective to avoid cross-hybridization caused by contamination of each gene amplification product into the other hybridization region. Detecting multiple genes from the same sample on the same microarray avoids erroneous determination due to a combination error of each gene sequence information that can occur due to a notation error on the container, etc., compared to using multiple containers. This is advantageous in that it can be performed.
  • the microarray of the present invention can stably hold a solution on a probe, the function can be exhibited only in a solution such as a molecular beacon probe if a device capable of measuring with a frame is used. Inappropriate props can be used. In diagnosis, high reliability and immediacy are required, and it is important to prevent false negatives due to contamination of nucleic acid amplification products with reagents before the gene amplification reaction and to shorten the detection time. Ishi guro T et al. Nucleic Acids Res. 1996 Dec 15; 24 (24): 4992-7, as shown in Orizu E et al. Molecular & Cellular Probes.
  • hybrid recognition probes such as the molecular beacon shown in 1998 Aug; 12 (4): 219-26
  • hybrid recognition probes do not require sample labeling and do not require further washing. Since detection is possible, the detection system is very simple and the risk of contamination is low. Therefore, the hybrid recognition probe is expected to be applied in the diagnostic field.
  • Application as a microarray probe has been attempted, but molecular beacons can be detected in a dry state as pointed out in Steemers FJ. Et al. Nature Biotechnology. 2000 Jan; 18 (l): 91-4.
  • it is difficult to dry with conventional microarrays and molecular beacons cannot be used as microarray probes because drying is indispensable for scanning.
  • microarray container according to the present invention is advantageous in that a hybrid recognition probe excellent in reliability and immediacy can be used since detection can be performed while a liquid is retained on a prop.
  • a removable lid can be used if necessary.
  • the lid prevents evaporation of the hybridization solution in the hybridization.
  • Evaporation of the hybridization solution is a problem because it changes the salt concentration of the hybridization solution, making it impossible to obtain the predetermined hybridization conditions.
  • the scattering of the hybridization solution containing the nucleic acid amplification product leads to serious inspection errors when it contaminates the amplification system. Therefore, the lid can be easily removed while maintaining the required hermeticity for operational reasons during the immobilization of the probe, injection of the sample onto the carrier surface during hybridization, and the washing process after hybridization. desirable.
  • the required tightness is sufficient to avoid evaporation that can cause large fluctuations in the liquid volume during hybridization and does not have to be strong enough to prevent the liquid from leaking out. Therefore, the lid can be a simple seal.
  • a lid or frame can be provided with an inlet or outlet for the hybridization solution to automate a series of reactions.
  • the carrier portion, frame, and, in some cases, the lid for detecting the target molecule according to the present invention are not particularly limited as long as they have a material having an impermeable surface, but when the detection is performed from the bottom of the microarray, it is preferably transparent.
  • Materials can be used. Examples of transparent materials include glass, plastics such as polystyrene and polypropylene, and processed products obtained by chemical treatment of these materials as required, and processed products coated with polymers such as nitrocellulose and polyacrylamide. .
  • the detection sensitivity can be increased by coating with aluminum or coloring the material black.
  • ultraviolet rays Zouali M and Stollar BD. J Immunol Methods.
  • the thickness of the microarray is not particularly limited, but is preferably such that it does not affect the light transmittance, and is generally about 0.5 mm to 2 mm.
  • a carrier for detecting a target molecule to which a molecule capable of capturing the target molecule (capture molecule) may be immobilized, and a frame for holding the sample on the carrier are provided.
  • Target molecule having multiple units consisting of Provided is a microarray for detecting the number of units, wherein a plurality of units are integrated by a frame holder, and a plurality of units are formed on a common carrier.
  • a carrier for detecting a target molecule to which a molecule capable of capturing the target molecule (capture molecule) may be immobilized, and a frame for holding a sample on the carrier are provided.
  • a microarray for detecting a target molecule comprising 2 to 10 units consisting of: a unit formed on the same carrier, and a unit formed by a frame holder at an opening of the frame.
  • An integrated microarray is provided.
  • a carrier for detecting a molecule of interest to which a molecule capable of capturing the molecule of interest (capture molecule) may be immobilized, and a sample held on a carrier
  • a microarray for detecting a target molecule comprising 2 to 10 units comprising a frame, a plurality of units being formed on a common carrier, and a plurality of units being formed at an opening of the frame.
  • a microarray is provided in which the frame is detachably fixed to the carrier by fitting the convex or concave portion of the frame with the concave or convex portion of the corresponding carrier.
  • a microarray set in which a plurality of microarrays according to the present invention are integrated.
  • a plurality of microarrays can be integrated by a microarray holder.
  • the microarray holder may be any one that can align and fix a plurality of microarrays, and may be, for example, a box-shaped holder (see Fig. 4) or a clip-shaped holder (see Fig. 6).
  • a plurality of microarrays can also be integrated by fitting one or more protrusions and / or recesses provided on the microarray (see FIG. 5). The uneven portion may be present on both the carrier and the frame holder, or may be present on either of them.
  • the microarray set integrated by the uneven portion may be further supported by a microarray holder (for example, a box-shaped holder).
  • the number of microarrays included in the microarray set is preferably 2 to 12.
  • a frame for holding a sample on a carrier for detecting a target molecule of a microarray wherein the frame is used by being immobilized on the carrier.
  • a frame is provided. This frame may be detachable from the carrier part.
  • This frame may also be provided with one or more convex portions or concave portions corresponding to one or more concave portions or convex portions provided on the carrier.
  • the frame can be detachably fixed to the carrier by fitting the convex or concave portion of the frame with the corresponding concave or convex portion of the carrier.
  • the sample can be a PCR amplified nucleic acid sample.
  • a nucleic acid label a fluorescent substance such as Cy3, a radioisotope, or a substance having an affinity for another substance such as hapten-dibiotin such as DNP can be used.
  • These labels can be prepared by using a primer whose terminal is labeled with an arbitrary labeling substance, or by introducing the labeling substance into a monomeric nucleic acid used for amplification in advance.
  • DNP or biotin it is necessary to add a substance (enzyme-labeled antibody or fluorescently-labeled streptavidin) that enables detection of these chemicals at the time of detection.
  • the probe is immobilized on the microarray according to the present invention
  • the probe is immobilized on the detection portion.
  • the sample is poured into the microarray according to the present invention, and the target nucleic acid is hybridized with the probe. Remove and wash the sample if necessary.
  • the target nucleic acid is detected. Even when detection is performed by chemiluminescence or color development, a stable result can be obtained because the reaction solution is stably maintained on the probe.
  • ELSA Endoza LG et al. Biotechniques. 1999 0ct; 27 (4 ): 778-80, 782-6, 788. It can also be used to analyze interactions between proteins (Emili AQ and Cagney G. Nat Biotechnol. 2000 Apr; 18 (4): 393-7).
  • a microarray container was prepared in which a frame was attached on a flat polystyrene plate so that the hybridization area was 152 mm 2 (19 mm ⁇ 8 mm).
  • 15 types of human leukocyte antigen gene DRB 1 typing probes (# 1: DRB 2801 J, # 2: DRB1002J, # 3: DRB7004, # 4: DRB 1004, # 5: DRB5703J, # 6DRB3705J, # 7: DRB 10X YJ , # 8: DRB 1006, # 9: DRB70J, # 10: DRB 1007, # 11: DRB 1008J, # 12: DRB 1003NJ, # 13: DRB 1005, # 14: DRB7003, # 15: c ommon It was synthesized according to the method described in Kawai S et al. Eur JI employed unogenet. 1996 Dec; 23 (6): 471-86. This probe was spotted by a frame on the area formed on the polystyrene
  • the partial sequence of allyl * 1101 of the DRB1 gene was amplified by PCR according to the method described in Kawai S et al. Eur J I uno genet. 1996 Dec; 23 (6): 471-86. However, the 5 'end of the primer was labeled with fluorescein instead of the biotin described in the literature to obtain a fluorescein-labeled amplification product.
  • the PCR product was purified, diluted with 1 OxSSC to a final concentration of 1 OnM, and used as a solution for hybridization.
  • the hybridization solution was removed, and the plate was washed three times with 1 ⁇ SSC.
  • the container according to the present invention enables gene detection and typing. It became clear.

Abstract

A micro-array excellent in operability and data reliability, and suitable for mass specimen-treating. A micro-array for detecting a target molecule, comprising at least one unit consisting of a carrier for detecting a target molecule and allowing a target-molecule-capturable molecule (capturing molecule) to be fixed, and a frame for retaining a sample on the carrier.

Description

明 細 書 マイクロアレイ 発明の背景  Description Microarray Background of the Invention
発明の分野  Field of the invention
本発明は生体分子の解析に用いられるマイクロアレイに関し、 更に詳細には大 量検体処理に適した診断用マイクロアレイに関する。  The present invention relates to a microarray used for analyzing biomolecules, and more particularly, to a diagnostic microarray suitable for processing a large amount of a sample.
関連技術  Related technology
近年、 DNA配列決定技術の飛躍的な進歩により、 大量の遺伝子配列が明らかにさ れている。 しかし、 多くの場合は塩基配列のみでは遺伝子の機能の特定は困難な ため、 発現解析を行わなければならない。  In recent years, breakthroughs in DNA sequencing technology have revealed a large number of gene sequences. However, in many cases, it is difficult to specify the function of a gene using only the nucleotide sequence, so expression analysis must be performed.
mRNAレベルでの遺伝子発現の解析は、 ノーザンプロット法 (Alwine JC et al. Proc Natl Acad Sci USA. 1977 Dec ; 74( 12) : 5350-4) のように、 試料に対し特定 の既知遺伝子配列をプローブとして用いる方法がある。 一方、 これとは逆に、 デ ィファレンシャルディスプレイ法 (Liang P and Pardee AB. Science. 1992 Aug 14;257(5072) : 967-71) のように、 異なる試料間で発現量の異なる遺伝子を探す 方法もある。  Analysis of gene expression at the mRNA level can be performed by analyzing a specific known gene sequence for a sample, as in the Northern blot method (Alwine JC et al. Proc Natl Acad Sci USA. 1977 Dec; 74 (12): 5350-4). There is a method used as a probe. On the other hand, conversely, genes with different expression levels among different samples, such as the differential display method (Liang P and Pardee AB. Science. 1992 Aug 14; 257 (5072): 967-71), are used. There are ways to find them.
ノーザンブロット法は時間と労力がかかり、 解析できる遺伝子の数は限られて いる。 少数の候補遺伝子について解析するのには確実で便利な方法であるが、 次 々に同定される膨大な数の遺伝子を網羅的に解析するのは非常に困難である。 一方、 ディファレンシャルディスプレイ法は、 異なる状態の細胞 '組織から抽 出された試料それそれからランダムに増幅したサンプルを電気泳動し、 バンドパ ターンを比較することで、 異なる試料間で強さの異なるバンドを抽出し、 塩基配 列を決定する。 多くの場合、 このバンドは遺伝子の全塩基配列を含むことはなく、 バンドから得られた部分配列と、 これまでに決定された遺伝子配列のデ一夕べ一 スを照らし合わせることによって遺伝子が同定される。 同定された遺伝子がどの ような状態の細胞で強く発現していたかということから機能を推定できる。  Northern blotting is time-consuming and labor-intensive, and the number of genes that can be analyzed is limited. Although it is a reliable and convenient method for analyzing a small number of candidate genes, it is very difficult to analyze the vast number of genes identified one after another. On the other hand, in the differential display method, a sample extracted from cells and tissues in different states and a sample amplified at random are electrophoresed, and band patterns are compared to extract bands with different intensities between different samples. And determine the base sequence. In many cases, this band does not contain the entire nucleotide sequence of the gene, and the gene is identified by comparing the partial sequence obtained from the band with the previously determined gene sequence data. You. The function can be estimated from the state of the identified gene that was strongly expressed in the cell.
しかし、 得られた配列が既知でない場合は、 ライプラリーからクロ一ニングし なければならない。 既知配列がある場合は、 遺伝子の同定は速やかに行われるが、 電気泳動の分解能の限界から、 発現量の変化をモニターできる遺伝子の数には限 界がある。 However, if the sequence obtained is not known, clone from the library. There must be. If there is a known sequence, the gene can be identified quickly, but the number of genes that can be monitored for changes in the expression level is limited due to the limitations of electrophoretic resolution.
これらの方法に比べて飛躍的に多くの遺伝子を解析できるのが、 DNAマイクロア レイ、 あるいは DNAチップと呼ばれる技術である。  A technique called DNA microarray or DNA chip is capable of analyzing a much larger number of genes than these methods.
DNAマイクロアレイは、 スライ ドグラスなどの微小な平板上に、 既知の遺伝子配 列の部分増幅物あるいはオリゴヌクレオチドを高密度で固相化したものであり、 ハイブリダイゼーシヨンによって数千から数万種の遺伝子の発現量を一枚のスラ ィド上で同時検出できる技術である。 DNAは担体上に直接的に固相合成されるかあ るいは、 予め合成したものを微細なピンなどでスポヅティングすることによって 担体に固定できる。  A DNA microarray is a solid plate in which a partial amplification product of a known gene sequence or an oligonucleotide is immobilized on a small plate such as a slide glass at a high density. Thousands to tens of thousands of types are obtained by hybridization. This technology allows simultaneous detection of gene expression levels on a single slide. DNA can be directly solid-phase synthesized on a carrier, or can be immobilized on a carrier by spotting a previously synthesized DNA with a fine pin or the like.
.DNAマイクロアレイは発現解析 ·多型解析の研究において非常に強力な手法とし て発展しつつあり、 今後はこれらの研究成果に基づいて臨床での応用が盛んにな つていくと考えられている (Hodgson J. Nat Biotechnol . 1998 Aug; 16(8) :725- 7) 。  DNA microarrays are being developed as a very powerful technique in expression analysis and polymorphism analysis research, and clinical applications are expected to become more active in the future based on these research results ( Hodgson J. Nat Biotechnol. 1998 Aug; 16 (8): 725-7).
しかし、 従来の DNAマイクロアレイにおけるハイブリダィゼ一シヨンでは、 Sch ena M et al . Science. 1995 Oct 20;270(5235) :467-70に記述されているように、 スライドグラス状のものにプロ一ブを固相化し、 プローブ上に検出対象を含むハ イブリダィゼ一シヨン溶液を乗せ、 カバ一スリップを被せることによって、 プロ ーブ領域全体に試料溶液を押し広げるのが一般的である。 夕ーゲット核酸群は蛍 光物質などで標識され、 ハイブリダィズした後、 プロ一ブにハイプリダイズしな かった余剰な標識核酸を洗浄によって除いている。  However, in the hybridization of a conventional DNA microarray, as described in Schena M et al. Science. 1995 Oct 20; 270 (5235): 467-70, the probe is placed on a slide glass. In general, the sample solution is spread over the entire probe area by immobilizing a solid phase, placing a hybridization solution containing a detection target on a probe, and covering the probe with a cover slip. The target nucleic acid group is labeled with a fluorescent substance or the like, and after hybridization, excess labeled nucleic acid not hybridized to the probe is removed by washing.
この方法は力バースリップを被せる際に試料溶液中に泡が入りやすいという問 題がある。 混入した泡はプローブと試料の接触を阻害して偽陰性の原因となる。 この問題を避けるために力バースリヅプの扱いには非常な慎重さが要求され、 大 量検体処理には大変な時間がかかる。  This method has a problem that bubbles easily enter the sample solution when a force bar slip is applied. The mixed bubbles inhibit contact between the probe and the sample and cause false negatives. To avoid this problem, very careful handling of force bar slips is required, and the processing of large samples takes a great deal of time.
さらに、 ハイプリダイゼ一シヨン溶液はカバースリップで覆われた狭い空間に 存在し、 攪抨が困難なため試料濃度の偏りが生じ、 試料量不足による偽陰性と試 料量過多による偽陽性の原因となるという問題点がある。 また、 力バースリップ領域内に過不足なくハイブリダイゼ一ション溶液を存在 させるには微妙な液量の調節が必要である。 同一担体上に二つ以上のプローブ領 域を存在させ、 この担体上でそれぞれのプロ一ブ領域に異なる試料を反応させる 時、 ハイブリッド溶液が過剰であるとカバ一スリヅプ領域外、 すなわちプローブ 領域外にハイブリダイゼーション溶液がはみ出し、 他のプローブ領域への試料の 混入を引き起こし、 クロスハイプリダイゼ一シヨンによる偽陽性の原因となる。 また、 ハイプリダイゼ一シヨンを終えた後には洗浄のために力パースリヅプを 取り外さなければならないが、 カバ一スリップは表面張力により担体上に強固に 吸着し、 速やかな取り外しが困難である。 Furthermore, the hybridization solution is present in a narrow space covered with a cover slip, and is difficult to disperse, resulting in a bias in the sample concentration, causing false negatives due to insufficient sample volume and false positives due to excessive sample volume. There is a problem. In order for the hybridization solution to be present in the force bar slip region without excess or deficiency, it is necessary to finely adjust the amount of the solution. When two or more probe regions are present on the same carrier and different samples are allowed to react with each probe region on this carrier, if the hybrid solution is excessive, it will be outside the cover slip region, that is, outside the probe region. In this case, the hybridization solution protrudes, causing the contamination of the sample with other probe regions, which causes false positives due to cross-hybridization. In addition, after finishing the hybridization, the force purse slip must be removed for cleaning, but the cover slip is strongly adsorbed on the carrier due to surface tension, and it is difficult to quickly remove it.
改良されたマイクロアレイ用力バースリヅプとして、 プローブを固相化した後 に担体に張り付ける蓋と枠が一体となったカバ一スリヅプが開発されている (Gr ace Bio-Labs, Inc, USA) 。 また、 96ウェルマイク口プレート内に DNA或いは抗体 をスポットする方法が開発されている (Genometrix社; Z.ipkin I . BioCentury. 1 999, Nov. 15,7:A9、 Mendoza LG et al . Biotechniques. 1999 0ct;27(4) :778-80, 782-6, 788) 。 しかしながら操作性およびデ一夕の信頼性は未だ満足のいくもの ではなかった。 発明の概要  As an improved microarray force bar strip, a cover strip that integrates a lid and a frame that is attached to a carrier after immobilizing the probe has been developed (Grace Bio-Labs, Inc, USA). In addition, a method of spotting DNA or antibody in a 96-well microphone opening plate has been developed (Genometrix; Z.ipkin I. BioCentury. 1999, Nov. 15, 7: A9, Mendoza LG et al. Biotechniques. 1999 0ct; 27 (4): 778-80, 782-6, 788). However, operability and reliability over time were not yet satisfactory. Summary of the Invention
本発明者らはマイクロアレイの検出部分に枠を設け、 サンプル (被検液) を検 出部分上に保持させる構成をとることにより、 ハイプリダイゼーションの操作性 および解析データの信頼性が向上することを見出した。  The present inventors improve the operability of hybridization and the reliability of analysis data by providing a frame in the detection part of the microarray and holding the sample (test liquid) on the detection part. Was found.
本発明は、 操作性と解析データの信頼性に優れ、 大量検体処理に適したマイク ロアレイの提供をその目的とする。  An object of the present invention is to provide a microarray excellent in operability and reliability of analysis data and suitable for processing a large number of samples.
本発明によれば、 複数の目的分子を検出するためのマイクロアレイであって、 目的分子を捕獲可能な分子 (捕獲分子) が固定化されていてもよい目的分子を検 出するための担体と、 サンプルを該担体上に保持するための枠とからなるュニヅ トを少なくとも一つ有するマイクロアレイが提供される。  According to the present invention, there is provided a microarray for detecting a plurality of target molecules, a carrier for detecting a target molecule to which a molecule capable of capturing the target molecule (capture molecule) may be immobilized, A microarray having at least one unit comprising a frame for holding a sample on the carrier is provided.
本発明によるマイクロアレイは、 枠の上に固定化された蓋がついていないため 捕獲分子をいつでも固定化することができ、 またァスピレー夕一ゃデイスペンザ —により洗净液の排出、 注入を簡便に行うことができる。 また本発明によるマイ クロアレイは枠をあらかじめ一体化しておけば、 検出工程における枠の取り付け 作業が不要であり、 枠が目的分子の検出の妨げとならないため取り外し作業も不 要である。 従って本発明によるマイクロアレイは操作性が優れている点で有利で める。 Since the microarray according to the present invention does not have an immobilized lid on the frame, the captured molecule can be immobilized at any time. This makes it easy to discharge and inject the washing liquid. In addition, if the frame is integrated in the microarray according to the present invention in advance, the work of attaching the frame in the detection step is unnecessary, and the work of removing the frame is not required because the frame does not hinder detection of the target molecule. Therefore, the microarray according to the present invention is advantageous in that it has excellent operability.
本発明によるマイクロアレイは溶液を検出部分に安定して保持させることがで きるため、 信頼性と即時性に優れたモレキュラービーコンプロ一ブのような溶液 中でのみ検出されうるプローブの使用が可能となる。 また本発明によるマイクロ アレイは、 同一担体上で複数検体を扱う場合であっても複数の検出領域を枠によ つて明確に分けることによつて各検体から別検体への混入を避けることができる 従って本発明によるマイクロアレイによれば誤判定のない信頼性あるデ一夕が得 られ、 大量の検体処理が可能である点で有利である。 図面の簡単な説明  Since the microarray according to the present invention can stably hold a solution on the detection portion, it is possible to use a probe that can be detected only in a solution such as a molecular beacon probe having excellent reliability and immediacy. Become. Further, in the microarray according to the present invention, even when a plurality of samples are handled on the same carrier, contamination of each sample into another sample can be avoided by clearly dividing a plurality of detection regions by a frame. Therefore, the microarray according to the present invention is advantageous in that a reliable data without erroneous determination can be obtained and a large amount of sample can be processed. BRIEF DESCRIPTION OF THE FIGURES
図 1は本発明によるマイクロアレイを示した図である。 梓 3が担体ポリスチレ ン 2に取り付けられている。 担体ポリスチレン 2上の枠 3で囲まれた領域がハイ プリダイゼーシヨン領域である。 Aは平面図、 Bは断面図、 Cは斜視図である。 図 2は本発明によるマイクロアレイを示した図である。 複数の枠 3が着脱可能 に担体ポリスチレン 2に取り付けられている。 担体ポリスチレン 2上の枠 3で囲 まれた領域がハイブリダィゼ一シヨン領域である。 Aは平面図、 Bは断面図、 C は斜視図である。  FIG. 1 is a diagram showing a microarray according to the present invention. Azusa 3 is attached to carrier polystyrene 2. A region surrounded by a frame 3 on the carrier polystyrene 2 is a hybridization region. A is a plan view, B is a sectional view, and C is a perspective view. FIG. 2 is a diagram showing a microarray according to the present invention. A plurality of frames 3 are detachably attached to the carrier polystyrene 2. A region surrounded by a frame 3 on the carrier polystyrene 2 is a hybridization region. A is a plan view, B is a sectional view, and C is a perspective view.
図 3は本発明によるマイクロアレイを示した図である。 枠ホルダ一 4により一 体化された複数の枠 3が、 着脱可能に担体ポリスチレン 2に取り付けられている c 担体ポリスチレン 2上の枠 3で囲まれた領域がハイブリダイゼ一ション領域であ る。  FIG. 3 is a diagram showing a microarray according to the present invention. A plurality of frames 3 integrated by the frame holders 14 are detachably attached to the carrier polystyrene 2 c. A region surrounded by the frame 3 on the carrier polystyrene 2 is a hybridization region.
図 4はマイクロアレイセットを示した図である。 Aはマイクロアレイ 5とマイ クロアレイホルダ一 6を示した図である。 Bは箱状のマイクロアレイホルダー 6 に複数のマイクロアレイ 5を設置することにより得られたマイクロアレイセヅト 7を示した図である。 図 5は担体 2および枠ホルダー 4に設けられた凹部 8および凸部 9を互いに嵌 合させることにより複数のマイクロアレイを一体化する態様を示した図である。 複数のマイクロアレイを凹凸部で一体化することによりマイクロアレイセットを 得ることがで,きる。 FIG. 4 shows a microarray set. A is a diagram showing a microarray 5 and a microarray holder 16. B is a diagram showing a microarray set 7 obtained by placing a plurality of microarrays 5 in a box-shaped microarray holder 6. FIG. 5 is a diagram showing an embodiment in which a plurality of microarrays are integrated by fitting concave portions 8 and convex portions 9 provided on the carrier 2 and the frame holder 4 to each other. A microarray set can be obtained by integrating a plurality of microarrays at uneven portions.
図 6はクリ ヅプ状のマイクロアレイホルダー 1 0により複数のマイクロアレイ を一体化する態様を示した図である。 複数のマイクロアレイをクリップ 1 0によ り一体化することによりマイクロアレイセットを得ることができる。  FIG. 6 is a view showing an embodiment in which a plurality of microarrays are integrated by a clip-shaped microarray holder 10. A microarray set can be obtained by integrating a plurality of microarrays with the clip 10.
図 7は本発明による枠を示した図である。 複数の枠 3が枠ホルダー 4により一 体化されている。  FIG. 7 is a diagram showing a frame according to the present invention. A plurality of frames 3 are integrated by a frame holder 4.
図 8は実施例における H L A D R B 1遺伝子タイビングの結果を示した図で ある。 発明の具体的説明  FIG. 8 is a diagram showing the results of HLADRB1 gene tying in the examples. Detailed description of the invention
本明細書において 「マイクロアレイ」 とは整理された捕獲分子群が担体上に固 定化されたものあるいはこれらを固定化可能な担体を意味し、 D N Aチップのよ うな 「検出用チップ」 またはそれを調製するための担体を含む意味で用いられる 本発明によるマイクロアレイは、 目的分子を検出するための担体と、 目的分子 の存在を検出するためのサンプル (被検液) を検出部分上に保持するための枠と からなるュニヅトを少なくとも一つ有する。 好ましくは該ュニヅトを 2〜: I 0、 より好ましくは 2 ~ 5個有する。  As used herein, the term “microarray” refers to a carrier in which a group of arranged capture molecules is immobilized on a carrier or a carrier capable of immobilizing the same, and is referred to as a “detection chip” such as a DNA chip or the like. The microarray according to the present invention, which is used to include a carrier for preparation, comprises a carrier for detecting a target molecule and a sample (test liquid) for detecting the presence of the target molecule on a detection portion. And at least one unit consisting of: It preferably has 2 to 10 units, more preferably 2 to 5 units.
本発明において 「ユニット」 とは枠により区切られた検出空間を意味する。 マ イクロアレイが複数のュニヅトを有する場合、 それぞれのュニットを構成する担 体は^通の担体であることができる。 すなわち、 共通の担体上に複数の枠を設置 することにより、 複数のユニットを形成させることができる。 例えば図 2および 3を参照。  In the present invention, “unit” means a detection space separated by a frame. When the microarray has a plurality of units, the carrier constituting each unit can be a common carrier. That is, a plurality of units can be formed by installing a plurality of frames on a common carrier. See, for example, FIGS.
担体には捕獲分子があらかじめ固定化されていてもよい。  The capture molecule may be immobilized on the carrier in advance.
検出される目的分子は、 抗原性を有する物質 (タンパク質、 糖タンパク質、 ァ ミノ酸等) あるいはこれらに対する抗体、 核酸 (D NA、 R N A等) 、 ペプチド 核酸等があるが、 特に臓器または骨髄移植時に問題となる白血球型 (H L A) の タイビングに有用と考えられる。 Target molecules to be detected include antigenic substances (proteins, glycoproteins, amino acids, etc.) or antibodies against them, nucleic acids (DNA, RNA, etc.), peptide nucleic acids, etc., especially during organ or bone marrow transplantation. Of the white blood cell type (HLA) It is considered useful for tying.
これらを検出する捕獲分子は抗原性を有する物質に対する抗体あるいは抗原性 を有する物質、 核酸プローブ、 核酸ァプ夕マ一 (Hermann T and Patel DJ. Scie nce. 2000 Feb 4 ;287(5454) :820-5) あるいはべプチド核酸 (Beier M and Hohei sel JD. Nucleic Acids Res. 1999 May l;27(9) : 1970-7) 等があり、 ストレプト アビジンのように検出対象分子に結合能を持つ分子であってもよい。好ましくは、 核酸プローブである。 核酸プローブは、 合成オリゴヌクレオチド、 プラスミド/フ ァージ、 ssMAのように生体内で増幅された核酸或いは PCR法などで試験管内で増 幅された核酸断片等を使用することができる。  The capture molecules for detecting these are antibodies against substances having antigenicity or substances having antigenicity, nucleic acid probes, nucleic acid probes (Hermann T and Patel DJ. Science. 2000 Feb 4; 287 (5454): 820 -5) or a peptide nucleic acid (Beier M and Hoheisel JD.Nucleic Acids Res. 1999 May l; 27 (9): 1970-7), etc., and a molecule such as streptavidin that has the ability to bind to the molecule to be detected. It may be. Preferably, it is a nucleic acid probe. As the nucleic acid probe, a synthetic oligonucleotide, a plasmid / phage, a nucleic acid amplified in a living body such as ssMA, or a nucleic acid fragment amplified in a test tube by PCR or the like can be used.
担体への捕獲分子の固相化は、 物理吸着あるいは化学結合により行える。 吸着 は Schena M et al. Science. 1995 Oct 20;270(5235) :467-70に示されているよう に担体ガラス表面を poly-L-Lysでコ一トし、 Lysのァミノ基の正電荷と DNAのリン 酸結合の負電荷間の静電作用を利用したものが代表的である。 この他にもマイク 口プレートで行われるように (Inouye S and Hondo R. J Clin Microbiol. 1990 The capture molecules can be immobilized on the carrier by physical adsorption or chemical bonding. As shown in Schena M et al. Science. 1995 Oct 20; 270 (5235): 467-70, the carrier glass surface was coated with poly-L-Lys and the positive charge of the Lys amino group was observed. A typical example is one utilizing the electrostatic action between the negative charge of the phosphate bond between DNA and DNA. In addition, as is done with the microphone mouth plate (Inouye S and Hondo R. J Clin Microbiol. 1990
Jun;28(6) :1469-72) 、 担体としてポリスチレンなどのプラスチヅクを用いて吸 着させる方法もある。 化学結合では文献 (Za誦 atteo N et al . Anal Biochem. 2 000 Apr 10 ;280(1) :143-50) であるように、 担体表面にアルデヒド基やカルボキ シル基、 アミノ基等の官能基を導入し、 その官能基と反応性のある官能基を導入 した DNAと結合させることによって行われる。 また、 ストレプトアビジンとビォチ ン、 抗体と抗原のように生体分子の結合能力を利用することもできる。 Jun; 28 (6): 1469-72), there is also a method of absorbing using a plastic such as polystyrene as a carrier. In chemical bonding, as described in the literature (Za recitation atteo N et al. Anal Biochem. 2000 Apr 10; 280 (1): 143-50), functional groups such as aldehyde groups, carboxyl groups, and amino groups are present on the carrier surface. This is performed by introducing DNA into which a functional group reactive with the functional group is introduced. In addition, the binding ability of biomolecules such as streptavidin and biotin, and antibodies and antigens can also be used.
捕獲分子は担体上に整理されて高密度に固定化されていることが好ましい。 プ ロープの高密度化によつて一度の実験で得られる情報量が飛躍的に増加し、 環境 の変化や疾患、 薬剤の投与などによって引き起こされる生体の状態の変化を、 全 体像 ·ネヅトヮ一ク像として捉えることが可能となる。 プローブの高密度化は例 えば Lipshutz RJ et al. Nat Genet. 1999 Jan;21(l Suppl ) :20- 4や Schena M et al. Science. 1995 Oct 20;270(5235) :467-70に記載の方法に従って実施できる。 ュニットを構成する枠は被検液を検出部分上に保持するのに充分な高さを有し ていればよく、 好ましくは 3 mm~ 1 5 mmであり、 さらに好ましくは 5 mm〜 1 O mmである。 本発明によるマイクロアレイは枠が備えられている。枠と担体とをあらかじめ 一体化しておけば検出前に枠を取り付ける作業が不要である。 また目的分子の検 出は枠により妨げられないので、 取り外し作業も不要となる。 従って操作手順の 簡便化が図られる点で有利である。 The capture molecules are preferably arranged on a carrier and immobilized at a high density. The amount of information obtained in a single experiment is dramatically increased due to the high density of the probe, and changes in the state of the living body caused by environmental changes, diseases, administration of drugs, etc. It can be captured as an image. Probe densification is described, for example, in Lipshutz RJ et al. Nat Genet. 1999 Jan; 21 (l Suppl): 20-4 and Schena M et al. Science. 1995 Oct 20; 270 (5235): 467-70. Can be performed according to the method described in It is sufficient that the frame constituting the unit has a height sufficient to hold the test liquid on the detection portion, preferably 3 mm to 15 mm, more preferably 5 mm to 1 O mm It is. The microarray according to the present invention is provided with a frame. If the frame and the carrier are integrated in advance, there is no need to attach the frame before detection. In addition, the detection of the target molecule is not hindered by the frame, so that the removal operation is not required. Therefore, it is advantageous in that the operation procedure can be simplified.
枠は必要に応じて、 脱着可能なものとすることもできる。 具体的には、 シリコ ンガスケットなどで枠と担体とを可逆的に接着することもできる。  The frame can be removable if required. Specifically, the frame and the carrier can be reversibly bonded with a silicon gasket or the like.
本発明によるマイクロアレイにおいては、 枠に 1または複数個の凸部または凹 部が設けられ、 かつ枠の凸部または凹部に対応して担体に凹部または凸部が設け られていてもよい。 枠の凸部または凹部と、 対応する担体の凹部または凸部とを 嵌合させることにより枠と担体とを着脱可能に固定化することもできる。  In the microarray according to the present invention, the frame may have one or more projections or depressions, and the carrier may have depressions or projections corresponding to the projections or depressions of the frame. The frame and the carrier can be detachably fixed by fitting the projection or the recess of the frame with the corresponding recess or the projection of the carrier.
本発明によるマイクロアレイにおいては、 複数のュニッ卜が枠ホルダーにより 一体化されていてもよい。 好ましくほ、 枠の開口部において、 複数のユニットが 一体化されていてもよい。 このような態様は図 3に示される通りである。 また複 数のュニヅトは一つの担体上に一列に並ぶように一体化されていてもよい。  In the microarray according to the present invention, a plurality of units may be integrated by a frame holder. Preferably, a plurality of units may be integrated in the opening of the frame. Such an embodiment is as shown in FIG. A plurality of units may be integrated on one carrier so as to be arranged in a line.
ユニットの形状は、 捕獲分子を効率よく、 かつ高密度に固定化するのに適した 直方体、 立方体或いはそれに準ずる形状が好ましく、 必要に応じて、 該ユニット に被検液の飛散、 蒸発を防ぐ目的で、 脱着可能な任意の蓋を具備していてもよい 従来のマイクロプレ一トの底面は円であり、 複数の独立した領域を並列させた 場合に各領域の間に捕獲分子を固相化できない領域が発生しており、 効率的に捕 獲分子を並べることができなかった。 本発明によるマイクロアレイでは整列した 捕獲分子群を担体に高密度に固定化することができ、 しかも固定化部分を効率よ く配置することができるため、 1つのマイクロアレイで多くの検体を一度に処理 することができる点で有利である。  The shape of the unit is preferably a rectangular parallelepiped, a cube, or a similar shape suitable for immobilizing the captured molecules efficiently and at high density. The purpose is to prevent the test liquid from scattering and evaporating to the unit as necessary. The bottom surface of a conventional microplate is a circle, and when a plurality of independent regions are arranged in parallel, capture molecules are immobilized between the regions. There were regions where the capture molecules could not be created, and the capture molecules could not be arranged efficiently. In the microarray according to the present invention, the aligned capture molecules can be immobilized on the carrier at high density, and the immobilized portion can be efficiently arranged, so that one microarray can process many samples at a time. This is advantageous in that it can be performed.
本発明によるマイクロアレイでは、 サンプル溶液が存在すべき担体部分 (例え ば、 プローブ固相化領域) が枠で囲まれており、 この枠がサンプル溶液 (例えば、 ハイブリダィゼ一シヨン溶液) のプローブ領域外への滲出を妨げる。 従って、 サ ンプル溶液が他の領域に広がっていくことを気にすることなく、 サンプル溶液を 担体部分に注入することができ、 操作が簡便となる点で有利である。  In the microarray according to the present invention, a carrier portion where a sample solution is to be present (for example, a probe-immobilized region) is surrounded by a frame, and this frame is moved out of the probe region of the sample solution (for example, a hybridization solution). Block oozing. Therefore, the sample solution can be injected into the carrier portion without worrying that the sample solution spreads to other regions, which is advantageous in that the operation is simplified.
枠によつて形成された空間内ではサンプル溶液は振とうにより自由に攪袢され うるので溶液内の目的分子の濃度の偏りや泡が捕獲分子上に留まることを回避で きる。 従ってより安定したハイブリダィゼ一シヨンが行える点で有利である。 本発明によるマイクロアレイは枠が固定ィ匕された蓋により覆われていないため 捕獲分子をいつでも固定化することが可能となる。 従って操作手順に柔軟性を持 たせることができる。 In the space formed by the frame, the sample solution is freely stirred by shaking. As a result, it is possible to prevent the concentration of the target molecule in the solution from being uneven and the bubbles from remaining on the capture molecule. Accordingly, it is advantageous in that more stable hybridization can be performed. Since the frame of the microarray according to the present invention is not covered with the lid on which the frame is fixed, the capture molecules can be immobilized at any time. Therefore, the operation procedure can be made flexible.
本発明によるマイクロアレイでは枠が固定化された蓋により覆われていないた め、 捕獲分子とサンプルとを反応させた後、 ノズルを持ったァスピレ一夕一とデ イスペンザ一を使用して検出領域を洗浄することができる。 ァスピレー夕一とデ イスペンサ一は例えばマイクロプレート洗浄機のようなものを使用できる。 従つ て本発明によるマイクロアレイはマイクロプレ一ト洗浄のように洗浄の自動化が 可能である点で有利である。 なおマイクロアレイ作製時において洗浄工程を自動 化することも可能である。  In the microarray according to the present invention, since the frame is not covered by the immobilized lid, after reacting the captured molecules with the sample, the detection area is set using an aspire with a nozzle and a dispenser. Can be washed. The aspirator and the dispenser can be, for example, a microplate washer. Therefore, the microarray according to the present invention is advantageous in that the washing can be automated as in the microplate washing. Note that it is also possible to automate the washing process when preparing a microarray.
また、 従来法ではハイプリダイゼ一ション後の洗浄液の除去は、 遠心あるいは 空気の噴射圧によって行っていた。 この場合ハイブリダィゼ一シヨン後の洗浄液 の塩が残る場合が多い。 表面に残つた塩はそれ自身が蛍光をもっているために、 スキャナーの感度を上げたときに不均一なノイズとなり、 微量試料の検出の妨げ となった。 また、 プローブスポット上に残った塩が大きな結晶になり、 励起光'蛍 光を遮蔽することにより偽陰性の原因となることもあった。 本発明は検出溶液を 保持したまま検出できるためかかる検出感度の低下が回避される点でも有利であ ο  Further, in the conventional method, the removal of the washing solution after the hybridization was performed by centrifugation or air injection pressure. In this case, the salt of the washing solution after the hybridization often remains. Since the salt remaining on the surface itself fluoresces, it caused non-uniform noise when the scanner sensitivity was increased, hindering the detection of trace samples. In addition, the salt remaining on the probe spot became a large crystal, which sometimes caused a false negative by blocking the excitation light and the fluorescence. The present invention is also advantageous in that detection can be performed while the detection solution is retained, and such a decrease in detection sensitivity is avoided.
本発明では必要に応じて枠を並列し複数のハイプリダイゼーション領域を形成 することができる。 複数ノヽィプリダイゼ一シヨン領域が枠によって物理的に分断 されていることは、 例えばヒト白血球抗原遺伝子 HLA- Aと HLA- Bのように非常に相 同性が高い遺伝子を同一担体上で検出する際に、 それぞれの遺伝子増幅産物がも う一方のハイブリダィゼ一シヨン領域へ混入することによって生じるクロスハイ プリダイゼ一シヨンを避けるのに非常に有効である。 同一マイクロアレイ上で同 一検体からの複数遺伝子を検出することは、 複数の容器を使用する場合に比べて、 容器への表記ミスなどから起こりうる各遺伝子配列情報の組み合わせミスによる 誤判定を避けることができる点で有利である。 また、 同一マイクロアレイ上で複数検体を扱う場合であっても複数のハィブリ ダイゼーシヨン領域を枠によって明確に分けることによつて各検体の別検体への 混入を避けることができる。 このような例としては、 衛生検査などでの菌類の検 出などが考えられる。 検出対象 (この場合は菌) の種類がマイクロアレイ担体で 一般的なスライドガラス一枚の領域をすベて使うほどはないが、 一枚のマイクロ アレイ上に同じプロ一ブセットを持った領域を複数設定することで、 多数検体処 理能力が向上する。 In the present invention, a plurality of hybridization regions can be formed by arranging frames as necessary. The fact that a plurality of nodipase regions are physically separated by a frame indicates that highly homologous genes such as the human leukocyte antigen genes HLA-A and HLA-B are detected on the same carrier. However, it is very effective to avoid cross-hybridization caused by contamination of each gene amplification product into the other hybridization region. Detecting multiple genes from the same sample on the same microarray avoids erroneous determination due to a combination error of each gene sequence information that can occur due to a notation error on the container, etc., compared to using multiple containers. This is advantageous in that it can be performed. Even when a plurality of specimens are handled on the same microarray, mixing of each specimen into another specimen can be avoided by clearly dividing the plurality of hybridization areas by a frame. An example of this would be the detection of fungi in hygiene inspections. Although the type of detection target (in this case, bacteria) is not enough to use the entire area of a single slide glass with a microarray carrier, multiple areas with the same probe set on a single microarray are used. By setting, the ability to process many samples is improved.
さらに、 本発明のマイクロアレイでは、 溶液をプロ一ブ上に安定して保持でき るため、 枠をつけたまま測定できる装置を用いれば、 モレキュラービーコンプロ —ブのような溶液中でしか機能を発揮できないプロ一プの使用が可能である。 診断においては高い信頼性と即時性が求められ、 遺伝子増幅反応前の試薬類へ の核酸増幅産物の汚染による偽陰性の防止や検出時間の短縮が重要である。 Ishi guro T et al. Nucleic Acids Res. 1996 Dec 15 ;24(24) :4992- 7で示されたよう なイン夕一カレ一夕一連結オリゴヌクレオチドや Ortiz E et al. Molecular & C ellular Probes. 1998 Aug; 12(4) :219-26で示されたモレキュラービーコンのよう に、 ハイブリダィゼ一シヨンによって信号を発するプローブ (ハイブリッド認識 プロ一プ) は試料標識の必要がなく、 さらに洗浄操作をしないで検出できるので 検出系が非常に簡便で、 汚染の危険性も低い。 従ってハイブリッド認識プローブ は診断分野における応用が期待されている。 マイクロアレイ用プロープとしての 応用も試みられているが、 Steemers FJ. et al. Nature Biotechnology. 2000 J an; 18( l) : 91-4にも指摘されているようにモレキュラービーコンは乾いた状態では 検出が難しく、 従来のマイクロアレイでは乾燥させることがスキャニングに不可 欠であるために、 マイクロアレイ用プローブとしてモレキュラービーコンを用い ることができない。 同様にィン夕一力レ一夕一連結ォリゴヌクレオチドに関して も従来法では困難であると予想される。 本発明によるマイクロアレイ容器はプロ ープ上に液体を保持したまま検出できることから信頼性と即時性に優れたハイブ リッド認識プローブを使用できる点で有利である。  Furthermore, since the microarray of the present invention can stably hold a solution on a probe, the function can be exhibited only in a solution such as a molecular beacon probe if a device capable of measuring with a frame is used. Inappropriate props can be used. In diagnosis, high reliability and immediacy are required, and it is important to prevent false negatives due to contamination of nucleic acid amplification products with reagents before the gene amplification reaction and to shorten the detection time. Ishi guro T et al. Nucleic Acids Res. 1996 Dec 15; 24 (24): 4992-7, as shown in Orizu E et al. Molecular & Cellular Probes. Probes that emit signals by hybridization (hybrid recognition probes), such as the molecular beacon shown in 1998 Aug; 12 (4): 219-26, do not require sample labeling and do not require further washing. Since detection is possible, the detection system is very simple and the risk of contamination is low. Therefore, the hybrid recognition probe is expected to be applied in the diagnostic field. Application as a microarray probe has been attempted, but molecular beacons can be detected in a dry state as pointed out in Steemers FJ. Et al. Nature Biotechnology. 2000 Jan; 18 (l): 91-4. However, it is difficult to dry with conventional microarrays, and molecular beacons cannot be used as microarray probes because drying is indispensable for scanning. Similarly, it is expected that the conventional method will also be difficult for oligonucleotides linked at once. The microarray container according to the present invention is advantageous in that a hybrid recognition probe excellent in reliability and immediacy can be used since detection can be performed while a liquid is retained on a prop.
本発明のマイクロアレイでは必要に応じて脱着可能な蓋を用いることができる。 蓋はハイブリダイゼ一シヨン中のハイプリダイゼ一ション溶液の蒸発を防ぐとと もに、 容器搬送中のハイプリダイゼ一ション溶液の容器外への飛散を避けること ができる。 ハイブリダイゼーション溶液の蒸発はハイプリダイゼ一ション溶液の 塩濃度を変化させ、 予め設定されたハイプリダイゼ一シヨン条件が得られなくな るので問題である。 また、 核酸増幅物を含むハイプリダイゼーシヨン溶液の飛散 は、 それが増幅系を汚染した場合に深刻な検査ミスにつながる。 従って、 蓋は、 プローブの固相化やハイプリダイゼ一ション時の試料の担体表面へ注入、 ハイブ リダィゼーシヨン後の洗浄過程での操作上の理由から、 必要な密閉性を保ちつつ も簡単に取り外せるものが望ましい。 必要な密封性とは、 ハイブリダィゼ一ショ ン中に液量が大きく変動するような蒸発を避ける程度のもので、 液が漏れ出すの を防く、ほど強固でなくても良い。 よって蓋は簡便なシール状のものでも可能であ る。 In the microarray of the present invention, a removable lid can be used if necessary. The lid prevents evaporation of the hybridization solution in the hybridization. In particular, it is possible to prevent the hybridization solution from scattering outside the container during the transfer of the container. Evaporation of the hybridization solution is a problem because it changes the salt concentration of the hybridization solution, making it impossible to obtain the predetermined hybridization conditions. Also, the scattering of the hybridization solution containing the nucleic acid amplification product leads to serious inspection errors when it contaminates the amplification system. Therefore, the lid can be easily removed while maintaining the required hermeticity for operational reasons during the immobilization of the probe, injection of the sample onto the carrier surface during hybridization, and the washing process after hybridization. desirable. The required tightness is sufficient to avoid evaporation that can cause large fluctuations in the liquid volume during hybridization and does not have to be strong enough to prevent the liquid from leaking out. Therefore, the lid can be a simple seal.
また、 必要に応じて蓋や枠にハイプリダイゼーシヨン溶液の吸入口や排出口を 設け、 一連の反応を自動化することも可能である。  If necessary, a lid or frame can be provided with an inlet or outlet for the hybridization solution to automate a series of reactions.
本発明による目的分子を検出するための担体部分、 枠、 および場合によっては 蓋は不透過性表面を有する素材であれば特に限定されないが検出をマイクロアレ ィの底面から行う場合、 好ましくは透明な素材を用いることができる。 透明な素 材としては、 ガラス、 ポリスチレンやポリプロピレン等のプラスチック類、 およ びこれらを必要に応じて薬品処理した加工物や二トロセルロース、 ポリアクリル アミドなどのポリマーをコートした加工物が挙げられる。 また、 検出に蛍光標識 を用いる場合、 アルミでコートしたり素材を黒色に着色し、 検出感度を上げるこ とができる。 好ましくは、 ポリスチレンまたはポリプロピレン等のプラスチック 類をタンパク質や核酸などの水溶性分子が付着しやすいように紫外線 (Zouali M and Stollar BD. J Immunol Methods. 1986 Jun 10; 90( 1) :105-10) や強酸 -強 塩基 (米国特許第 5712383号) などで処理をした加工物であることができる。 マイクロアレイの厚さは特に限定されないが、 光の透過性に影響を与えない程 度であることが好ましく、 通常 0 . 5 mm~ 2 mm程度である。  The carrier portion, frame, and, in some cases, the lid for detecting the target molecule according to the present invention are not particularly limited as long as they have a material having an impermeable surface, but when the detection is performed from the bottom of the microarray, it is preferably transparent. Materials can be used. Examples of transparent materials include glass, plastics such as polystyrene and polypropylene, and processed products obtained by chemical treatment of these materials as required, and processed products coated with polymers such as nitrocellulose and polyacrylamide. . When a fluorescent label is used for detection, the detection sensitivity can be increased by coating with aluminum or coloring the material black. Preferably, ultraviolet rays (Zouali M and Stollar BD. J Immunol Methods. 1986 Jun 10; 90 (1): 105-10) are used to attach plastics such as polystyrene or polypropylene to water-soluble molecules such as proteins and nucleic acids. And a strong acid-strong base (US Pat. No. 5,712,383). The thickness of the microarray is not particularly limited, but is preferably such that it does not affect the light transmittance, and is generally about 0.5 mm to 2 mm.
本発明によるマイクロアレイの好ましい態様によれば、 目的分子を捕獲可能な 分子 (捕獲分子) が固定化されていてもよい目的分子検出するための担体と、 サ ンプルを担体上に保持するため枠とからなる複数のュニットを有する、 目的分子 を検出するためのマイクロアレイであって、 複数のュニットが枠ホルダ一により 一体化され、 かつ複数のュニットが共通の担体上に形成されているマイクロアレ ィが提供される。 According to a preferred embodiment of the microarray according to the present invention, a carrier for detecting a target molecule to which a molecule capable of capturing the target molecule (capture molecule) may be immobilized, and a frame for holding the sample on the carrier are provided. Target molecule having multiple units consisting of Provided is a microarray for detecting the number of units, wherein a plurality of units are integrated by a frame holder, and a plurality of units are formed on a common carrier.
本発明によるマイクロアレイのより好ましい態様によれば、 目的分子を捕獲可 能な分子 (捕獲分子) が固定化されていてもよい目的分子検出するための担体と、 サンプルを担体上に保持するため枠とからなる 2〜 1 0個のュニヅトを有する、 目的分子を検出するためのマイクロアレイであって、 ュニットが同一担体上に形 成されており、 かつ枠の開口部において、 ユニットが枠ホルダ一により一体ィ匕さ れているマイクロアレイが提供される。  According to a more preferred embodiment of the microarray according to the present invention, a carrier for detecting a target molecule to which a molecule capable of capturing the target molecule (capture molecule) may be immobilized, and a frame for holding a sample on the carrier are provided. A microarray for detecting a target molecule, comprising 2 to 10 units consisting of: a unit formed on the same carrier, and a unit formed by a frame holder at an opening of the frame. An integrated microarray is provided.
本発明によるマイクロアレイのより最も好ましい態様によれば、 目的分子を捕 獲可能な分子 (捕獲分子) が固定化されていてもよい目的分子検出するための担 体と、 サンプルを担体上に保持するため枠とからなる 2〜1 0個のュニットを有 する、 目的分子を検出するためのマイクロアレイであって、 複数のユニットが共 通の担体上に形成されており、 枠の開口部において、 複数のユニットが枠ホルダ —により一体化されており、 枠に 1または複数個の凸部または凹部が設けられ、 枠の凸部または凹部に対応して担体に凹部または凸部が設けられており、 枠の凸 部または凹部と、 対応する担体の凹部または凸部とを嵌合させることにより枠が 担体に着脱可能に固定化されているマイクロアレイが提供される。  According to a most preferred embodiment of the microarray according to the present invention, a carrier for detecting a molecule of interest to which a molecule capable of capturing the molecule of interest (capture molecule) may be immobilized, and a sample held on a carrier A microarray for detecting a target molecule, comprising 2 to 10 units comprising a frame, a plurality of units being formed on a common carrier, and a plurality of units being formed at an opening of the frame. Unit is integrated by a frame holder, one or more projections or depressions are provided on the frame, and a depression or projection is provided on the carrier corresponding to the projection or depression of the frame, A microarray is provided in which the frame is detachably fixed to the carrier by fitting the convex or concave portion of the frame with the concave or convex portion of the corresponding carrier.
本発明によれば、 本発明による複数のマイクロアレイが一体化されてなる、 マ イクロアレイセヅトが提供される。 複数のマイクロアレイはマイクロアレイホル ダ一により一体化することができる。 マイクロアレイホルダーは複数のマイクロ アレイを整列して固定できるものであればよく、 例えば、 箱状のホルダ一 (図 4 参照) やクリップ状のホルダ一 (図 6参照) であることができる。複数のマイク ロアレイはまた、 マイクロアレイに設けられた 1または複数個の凸部および/ま たは凹部を嵌合させることにより一体化することができる (図 5参照) 。 凹凸部 は担体および枠ホルダーの両方にあっても、 いずれかにあってもよい。 凹凸部に より一体化されたマイクロアレイセットは、 更にマイクロアレイホルダ一 (例え ば箱状のホルダ一) により支持されてもよい。 マイクロアレイセットに含まれる マイクロアレイの数は好ましくは 2〜1 2個である。 本発明のもう一つの態様によれば、 マイクロアレイの目的分子を検出するため の担体上にサンプルを保持するための枠であって、 該担体上に固定化されて使用 されることを特徴とする枠が提供される。 この枠は担体部分に着脱可能であって もよい。 According to the present invention, there is provided a microarray set in which a plurality of microarrays according to the present invention are integrated. A plurality of microarrays can be integrated by a microarray holder. The microarray holder may be any one that can align and fix a plurality of microarrays, and may be, for example, a box-shaped holder (see Fig. 4) or a clip-shaped holder (see Fig. 6). A plurality of microarrays can also be integrated by fitting one or more protrusions and / or recesses provided on the microarray (see FIG. 5). The uneven portion may be present on both the carrier and the frame holder, or may be present on either of them. The microarray set integrated by the uneven portion may be further supported by a microarray holder (for example, a box-shaped holder). The number of microarrays included in the microarray set is preferably 2 to 12. According to another aspect of the present invention, there is provided a frame for holding a sample on a carrier for detecting a target molecule of a microarray, wherein the frame is used by being immobilized on the carrier. A frame is provided. This frame may be detachable from the carrier part.
この枠はまた、 担体に設けられた 1または複数個の凹部または凸部に対応して、 1または複数個の凸部または凹部が設けられていてもよい。 この場合、 枠の凸部 または凹部と対応する担体の凹部または凸部とを嵌合させることにより枠を担体 に着脱可能に固定化することができる。  This frame may also be provided with one or more convex portions or concave portions corresponding to one or more concave portions or convex portions provided on the carrier. In this case, the frame can be detachably fixed to the carrier by fitting the convex or concave portion of the frame with the corresponding concave or convex portion of the carrier.
以下、 サンプルが核酸である場合について検出方法を説明する。  Hereinafter, a detection method in the case where the sample is a nucleic acid will be described.
サンプルは P C R増幅された核酸試料であることができる。核酸の標識は、 Cy 3などの蛍光物質、 放射性同位体、 あるいは DNPなどのハプテンゃビォチンなどの ように他の物質に親和性のあるものを用いることができる。 これらの標識は、 末 端を任意の標識物質で標識したプライマーを用いるか、 増幅時に使用されるモノ マ一核酸に予め該標識物質を導入しておくことにより、 調製することができる。 なお、 DNPやピオチンを用いる場合は、 検出の際にこれらの化学物質を検出可能に する物質 (酵素標識抗体や蛍光標識ストレプトアビジン) を反応系に加える必要 がある。  The sample can be a PCR amplified nucleic acid sample. As a nucleic acid label, a fluorescent substance such as Cy3, a radioisotope, or a substance having an affinity for another substance such as hapten-dibiotin such as DNP can be used. These labels can be prepared by using a primer whose terminal is labeled with an arbitrary labeling substance, or by introducing the labeling substance into a monomeric nucleic acid used for amplification in advance. When DNP or biotin is used, it is necessary to add a substance (enzyme-labeled antibody or fluorescently-labeled streptavidin) that enables detection of these chemicals at the time of detection.
本発明によるマイクロアレイにプロ一ブが固定化されていない場合には検出部 分にプローブを固定化する。  When the probe is not immobilized on the microarray according to the present invention, the probe is immobilized on the detection portion.
次いで、 サンプルを本発明によるマイクロアレイに注ぎ、 目的核酸をプローブ とハイブリダィズさせる。 必要であればサンプルを取り除いて洗浄する。  Next, the sample is poured into the microarray according to the present invention, and the target nucleic acid is hybridized with the probe. Remove and wash the sample if necessary.
ハイブリダイゼ一ション後に目的核酸を検出する。 化学発光や発色によって検 出を行う場合にも、 反応溶液をプロ一プ上に安定に保持するので安定した結果を 得ることができる。  After the hybridization, the target nucleic acid is detected. Even when detection is performed by chemiluminescence or color development, a stable result can be obtained because the reaction solution is stably maintained on the probe.
上記以外にも、 m NAから翻訳されて生じるタンパク質の量と活性を調べること により、 直接細胞の状態を知ることもできる。 その場合、 同一担体上に異なる抗 原 Z抗体をスポットし、 種種の蛋白質を ELSAなどの免疫学的な方法で一度に検出 することもできる (Mendoza LG et al . Biotechniques. 1999 0ct;27(4) :778-80, 782-6, 788) 。 また、 タンパク質間の相互作用の解析にも使用できる (Emili AQ and Cagney G. Nat Biotechnol. 2000 Apr; 18(4) :393-7) 。 In addition to the above, by examining the amount and activity of a protein translated from mRNA, the state of a cell can be directly known. In this case, different antigen Z antibodies can be spotted on the same carrier, and various proteins can be detected at once by immunological methods such as ELSA (Mendoza LG et al. Biotechniques. 1999 0ct; 27 (4 ): 778-80, 782-6, 788). It can also be used to analyze interactions between proteins (Emili AQ and Cagney G. Nat Biotechnol. 2000 Apr; 18 (4): 393-7).
実 施 例  Example
本発明による生体分子検出容器の実施例を図 1を元に説明する。  An embodiment of a biomolecule detection container according to the present invention will be described with reference to FIG.
平坦なポリスチレン板上にハイプリダイゼ一シヨン領域が 152 mm2に (19 mm X 8 mm) なるように枠が取り付けられたマイクロアレイ容器を用意した。 ヒト白血球抗原遺伝子 DRB 1タイピング用プローブ 15種類 (# 1 : DRB 2801 J, #2 : DRB1002J, #3 : DRB7004, #4 : DRB 1 004, #5 : DRB5703J, #6DRB3705J, #7 : DRB 10X YJ, #8 : DRB 1006, #9 : DRB70J, #10 : DRB 1007, #11 : DRB 1008J, #12 : DRB 1003NJ、 #13 : DRB 10 05, #14 : DRB7003, #15 : c ommo n) を Kawai S et al. Eur J I雇 unogenet. 1996 Dec;23(6) :471-86に記載の方法に従って合成した。 このプ ローブを枠によってポリスチレン板上に形成された領域にスポットし、 物理吸着 によって固相化した。 A microarray container was prepared in which a frame was attached on a flat polystyrene plate so that the hybridization area was 152 mm 2 (19 mm × 8 mm). 15 types of human leukocyte antigen gene DRB 1 typing probes (# 1: DRB 2801 J, # 2: DRB1002J, # 3: DRB7004, # 4: DRB 1004, # 5: DRB5703J, # 6DRB3705J, # 7: DRB 10X YJ , # 8: DRB 1006, # 9: DRB70J, # 10: DRB 1007, # 11: DRB 1008J, # 12: DRB 1003NJ, # 13: DRB 1005, # 14: DRB7003, # 15: c ommon It was synthesized according to the method described in Kawai S et al. Eur JI employed unogenet. 1996 Dec; 23 (6): 471-86. This probe was spotted by a frame on the area formed on the polystyrene plate, and solidified by physical adsorption.
DRB 1遺伝子のァリル *1101の部分配列を Kawai S et al. Eur J I雇 uno genet. 1996 Dec;23(6):471-86に記載の方法に従って P CRによって増幅した。 ただし、 プライマー 5' 末端は文献記載のビォチンではなくフルォレセインによ つて標識することによってフルォレセィン標識された増幅産物を得た。  The partial sequence of allyl * 1101 of the DRB1 gene was amplified by PCR according to the method described in Kawai S et al. Eur J I uno genet. 1996 Dec; 23 (6): 471-86. However, the 5 'end of the primer was labeled with fluorescein instead of the biotin described in the literature to obtain a fluorescein-labeled amplification product.
PCR産物を精製し、 1 OxSSCで終濃度 1 OnMになるように希釈し、 ノ、 ィブリダイゼーシヨン溶液とした。  The PCR product was purified, diluted with 1 OxSSC to a final concentration of 1 OnM, and used as a solution for hybridization.
プローブ固相化領域にハイブリダイゼーション溶液 200 / Lを注入し、 45 。Cで 2時間ハイブリダイゼ一ションを行った。 ハイプリダイゼ一シヨン中はシ一 ルによって蓋をした。  Inject 200 / L of hybridization solution into the probe-immobilized area, 45. Hybridization was performed at C for 2 hours. The lid was closed with a seal during the hypride treatment.
ハイブリダィゼ一シヨン溶液を除き、 1 X S S Cで 3回洗った。  The hybridization solution was removed, and the plate was washed three times with 1 × SSC.
洗浄後に、 蛍光顕微鏡を使用して各プロ一ブスポッ卜の蛍光値を測定した。 表 1に示したように、 DRB 1*1101に特異的なプローブ (#5、 #7、 # 12) と全ァリル共通プロ一プ (#15) において蛍光が検出された。  After washing, the fluorescence value of each probe spot was measured using a fluorescence microscope. As shown in Table 1, fluorescence was detected with the probes (# 5, # 7, # 12) specific for DRB 1 * 1101 and the common allyl probe (# 15).
以上により、 本発明による容器で、 遺伝子の検出およびタイピングが可能なこ とが明らかになった。 As described above, the container according to the present invention enables gene detection and typing. It became clear.

Claims

請 求 の 範 囲 The scope of the claims
1. 目的分子を検出するためのマイクロアレイであって、 目的分子を捕獲可 能な分子 (捕獲分子) が固定化されていてもよい目的分子を検出するための担体 と、 サンプルを担体上に保持するための枠とからなるュニットを少なくとも一つ 有するマイクロアレイ。 1. A microarray for detecting the target molecule, a carrier for detecting the target molecule on which a molecule capable of capturing the target molecule (capture molecule) may be immobilized, and a sample held on the carrier A microarray having at least one unit comprising a frame for performing the operation.
2. 担体に捕獲分子が固定化された、 請求項 1に記載のマイクロアレイ。 2. The microarray according to claim 1, wherein the capture molecule is immobilized on a carrier.
3. 担体が透明な素材からなる、 請求項 1または 2に記載のマイクロアレイ c3. The microarray c according to claim 1 or 2, wherein the carrier is made of a transparent material.
4. 担体がガラス、 プラスチヅク、 シリコン、 またはこれらの加工物である 請求項 1〜3のいずれか一項に記載のマイクロアレイ。 4. The microarray according to any one of claims 1 to 3, wherein the carrier is glass, plastic, silicon, or a processed product thereof.
5. ユニットが脱着可能な蓋を更に有する、 請求項 1~4のいずれか一項に 記載のマイクロアレイ。  5. The microarray according to any one of claims 1 to 4, wherein the unit further has a removable lid.
6. ユニットが立方体、 直方体、 またはそれに準ずる形状である、 請求項 1 〜 5のいずれか一項に記載のマイクロアレイ。  6. The microarray according to any one of claims 1 to 5, wherein the unit is a cube, a rectangular parallelepiped, or a shape similar thereto.
7. 枠の高さが 3mm~ 15mmである、 請求項 1〜 6のいずれか一項に記 載のマイクロアレイ。  7. The microarray according to any one of claims 1 to 6, wherein the height of the frame is 3 mm to 15 mm.
8. 枠が担体から脱着可能である、 請求項 1〜7のいずれか一項に記載のマ イクロアレイ。  8. The microarray according to any one of claims 1 to 7, wherein the frame is detachable from the carrier.
9. ユニットを複数個有する、 請求項 1〜8に記載のマイクロアレイ。  9. The microarray according to any one of claims 1 to 8, comprising a plurality of units.
10. ユニットを 2〜10個有する、 請求項 9に記載のマイクロアレイ。 10. The microarray according to claim 9, having 2 to 10 units.
11. 捕獲分子が核酸、 ペプチド核酸、 抗体、 または抗原である、 請求項 1 〜 10のいずれか一項に記載のマイクロアレイ。 11. The microarray according to any one of claims 1 to 10, wherein the capture molecule is a nucleic acid, a peptide nucleic acid, an antibody, or an antigen.
12. 目的分子が HLA遺伝子である、 請求項 1〜11のいずれか一項に記 載のマイクロアレイ。  12. The microarray according to any one of claims 1 to 11, wherein the target molecule is an HLA gene.
13. 請求項 1〜12のいずれか一項に記載の複数のマイクロアレイが一体 化されてなる、 マイクロアレイセット。  13. A microarray set, wherein the plurality of microarrays according to any one of claims 1 to 12 are integrated.
14. 複数のマイクロアレイがマイクロアレイホルダ一により一体ィ匕された、 請求項 13に記載のマイクロアレイセヅト。  14. The microarray set according to claim 13, wherein a plurality of microarrays are integrated by a microarray holder.
15. 複数のマイクロアレイがマイクロアレイに設けられた 1または複数個 の凸部および/または凹部を嵌合させることにより一体化された、 請求項 1 3に 記載のマイクロアレイセヅト。 15. One or more microarrays provided on a microarray The microarray set according to claim 13, wherein the microarray set is integrated by fitting a convex portion and / or a concave portion of the microarray.
1 6 . マイクロアレイの目的分子を検出するための担体上にサンプルを保持 するための枠であって、 担体上に固定化されて使用されることを特徴とする枠。  16. A frame for holding a sample on a carrier for detecting a target molecule of a microarray, wherein the frame is used by being immobilized on the carrier.
1 7 . 担体に脱着可能である、 請求項 1 6に記載の枠。  17. The frame according to claim 16, which is detachable from a carrier.
PCT/JP2001/002821 2000-07-10 2001-03-30 Micro-array WO2002004951A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001244687A AU2001244687A1 (en) 2000-07-10 2001-03-30 Micro-array

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000208317 2000-07-10
JP2000-208317 2000-07-10

Publications (1)

Publication Number Publication Date
WO2002004951A1 true WO2002004951A1 (en) 2002-01-17

Family

ID=18704921

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/002821 WO2002004951A1 (en) 2000-07-10 2001-03-30 Micro-array

Country Status (2)

Country Link
AU (1) AU2001244687A1 (en)
WO (1) WO2002004951A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003227841A (en) * 2002-02-01 2003-08-15 Fuji Photo Film Co Ltd Method for association reaction between receptor and ligand and unit for biochemical analysis used for the same
JP2004045179A (en) * 2002-07-11 2004-02-12 Nisshinbo Ind Inc Base material for microarray
JP2004138571A (en) * 2002-10-21 2004-05-13 Joji Inasawa Efficient detection instrument using biochemical detection micro-array
JP2004177345A (en) * 2002-11-28 2004-06-24 Sumitomo Bakelite Co Ltd Plastic substrate for micro array
JP2005515773A (en) * 2002-01-28 2005-06-02 ナノスフェアー インコーポレイテッド Hybridization apparatus and method
JP2005185171A (en) * 2003-12-25 2005-07-14 Canon Inc Probe set for identifying hla-dr allele and method for identifying the same
JP2006509201A (en) * 2002-12-04 2006-03-16 インターナショナル・ビジネス・マシーンズ・コーポレーション Surface treatment method
US7264845B2 (en) 2003-04-29 2007-09-04 The Procter & Gamble Company Method for increasing the hydrophobicity of a lavatory bowl surface
US9863884B2 (en) 2012-08-10 2018-01-09 Hamamatsu Photonics K.K. Surface-enhanced Raman scattering element, and method for producing same
US9863883B2 (en) 2012-08-10 2018-01-09 Hamamatsu Photonics K.K. Surface-enhanced raman scattering element
US10408761B2 (en) 2012-08-10 2019-09-10 Hamamatsu Photonics K.K. Surface-enhanced Raman scattering element
JP2020016658A (en) * 2012-09-28 2020-01-30 ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー Methods, systems, and arrays for biomolecular analysis
US11565231B2 (en) 2012-02-07 2023-01-31 Vibrant Holdings, Llc Substrates, peptide arrays, and methods
US11674956B2 (en) 2012-09-28 2023-06-13 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025962U (en) * 1983-07-27 1985-02-21 山本 康裕 urinalysis paper
JPH01102360A (en) * 1987-10-16 1989-04-20 Nissha Printing Co Ltd Reaction tester
JPH01102869U (en) * 1987-12-28 1989-07-11

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025962U (en) * 1983-07-27 1985-02-21 山本 康裕 urinalysis paper
JPH01102360A (en) * 1987-10-16 1989-04-20 Nissha Printing Co Ltd Reaction tester
JPH01102869U (en) * 1987-12-28 1989-07-11

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005515773A (en) * 2002-01-28 2005-06-02 ナノスフェアー インコーポレイテッド Hybridization apparatus and method
JP2003227841A (en) * 2002-02-01 2003-08-15 Fuji Photo Film Co Ltd Method for association reaction between receptor and ligand and unit for biochemical analysis used for the same
JP2004045179A (en) * 2002-07-11 2004-02-12 Nisshinbo Ind Inc Base material for microarray
JP2004138571A (en) * 2002-10-21 2004-05-13 Joji Inasawa Efficient detection instrument using biochemical detection micro-array
JP2004177345A (en) * 2002-11-28 2004-06-24 Sumitomo Bakelite Co Ltd Plastic substrate for micro array
JP2006509201A (en) * 2002-12-04 2006-03-16 インターナショナル・ビジネス・マシーンズ・コーポレーション Surface treatment method
US7264845B2 (en) 2003-04-29 2007-09-04 The Procter & Gamble Company Method for increasing the hydrophobicity of a lavatory bowl surface
JP2005185171A (en) * 2003-12-25 2005-07-14 Canon Inc Probe set for identifying hla-dr allele and method for identifying the same
US11565231B2 (en) 2012-02-07 2023-01-31 Vibrant Holdings, Llc Substrates, peptide arrays, and methods
US9863884B2 (en) 2012-08-10 2018-01-09 Hamamatsu Photonics K.K. Surface-enhanced Raman scattering element, and method for producing same
US9863883B2 (en) 2012-08-10 2018-01-09 Hamamatsu Photonics K.K. Surface-enhanced raman scattering element
US10408761B2 (en) 2012-08-10 2019-09-10 Hamamatsu Photonics K.K. Surface-enhanced Raman scattering element
JP2020016658A (en) * 2012-09-28 2020-01-30 ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー Methods, systems, and arrays for biomolecular analysis
US11674956B2 (en) 2012-09-28 2023-06-13 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
US11815512B2 (en) 2012-09-28 2023-11-14 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis

Also Published As

Publication number Publication date
AU2001244687A1 (en) 2002-01-21

Similar Documents

Publication Publication Date Title
US20230313279A1 (en) Methods of determining the location of an analyte in a biological sample using a plurality of wells
US6258593B1 (en) Apparatus for conducting chemical or biochemical reactions on a solid surface within an enclosed chamber
EP1608952B1 (en) Assay apparatus and method using microfluidic arrays
WO2002004951A1 (en) Micro-array
US7138268B2 (en) Dry biochemical assay plate and method for making the same
JP6751970B2 (en) Flow systems and methods for digital counting
WO2007029616A1 (en) Various substances supporter, various substances supporter processing apparatus, and method of mentioned processing
JP2010506583A (en) Nucleic acid amplification and detection device
AU2008208342A1 (en) Analysis chip and analysis method
EP1718411B1 (en) A device for analysing an interaction between target and probe molecules
WO2019178033A1 (en) Ultrahigh throughput protein discovery
US20050106607A1 (en) Biochip containing reaction wells and method for producing same and use thereof
Xiao et al. Immobilized OBOC combinatorial bead array to facilitate multiplicative screening
EP2038074B1 (en) Make and use of surface molecules of varied densities
JP3955952B2 (en) Analytical method of specimen by molecular array using micro infrared spectroscopy
EP1258731B1 (en) Reactive solid support for DNA fragment detection
WO2005064334A1 (en) Reaction vessel utilizing article having three-dimensionally arranged particles and reaction apparatus
US6500921B1 (en) Schiff base reductant co-dispense process
KR100813266B1 (en) Method for removing air bubbles from hybridization solution of a microarray-cover slip assembly and a microarray kit for the same
EP4357788A1 (en) Method for analyzing specimen, and specimen analyzing device
US20070037174A1 (en) Chemiluminescent generated fluorescent labeling
JP7354749B2 (en) Analytical chip testing method, testing device, and analytical chip manufacturing method
JP2022114583A (en) Method for manufacturing target measurement device, and kit for target measurement
JP2004170372A (en) Manufacturing method of biomolecule detecting apparatus
Beutling et al. Epitope analysis using synthetic peptide repertoires prepared by SPOT synthesis technology

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase